Predictors of PSA screening among men over 40 years of age who had ever heard about PSA

Korean Journal of Urology

Volumn 51, Issue 6, 2010, Pages 391-397

  Seo, Hyung K ^a   Lee, Nam Kyu ^b  

^a Konyang University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Mass screening; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; DEMOGRAPHY; EDUCATIONAL STATUS; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POVERTY; PREDICTION; RELIABILITY; SELF REPORT; SOCIAL STATUS;

EID: 77953762870     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.6.391     Document Type: Article

References (14)

1. Klein EA, Platz EA, Thompson IM. Epidemiology, etiology, and prevention of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007;2854-73.
2. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003;289:1414-20.
3. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberg D, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75. (Pubitemid 32166445)
4. Smith DS, Bullock AD, Catalona WJ, Herschman JD. Racial differences in a prostate cancer screening study. J Urol 1996;156:1366-9.
5. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst 2001;93:705-9. (Pubitemid 32492812)
6. Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004;38:732-44.
7. Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Solar-Vila H, et al. Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 2008;17:2825-34.
8. Resnick MJ, Canter DJ, Guzzo TJ, Bruker BM, Bergey M, Sonnad SS, et al. Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology 2009;73:620-3.
9. Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 2008;180:2423-9.
10. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009;20:417-35.
11. Pearlman DN, Rakowski W, Ehrich B, Clark MA. Breast cancer screening practices among black, Hispanic, and white women: reassessing differences. Am J Prev Med 1996;12:327-37. (Pubitemid 26376172)
12. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women's adherence to mammography screening guidelines. Health Serv Res 1998;33:29-53. (Pubitemid 28163070)
13. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care 1998;36:257-70.
14. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.